From GlobeNewswire: 2024-11-21 09:00:00

The PET-CT Scanner Device Market was valued at USD 2.30 billion in 2023 and is projected to reach USD 3.98 billion by 2032, growing at a CAGR of 6.30%. The market is driven by the demand for early diagnosis of medical conditions like cancer and advancements in imaging technology improving precision and efficiency.

The PET-CT scanner market is witnessing growth due to technological innovations, population aging, and increasing diseases like cancer and neurological disorders. The combination of PET with CT offers high-resolution imaging for early detection and monitoring of disease progression.

PET-CT scanners are in demand for effective disease prognosis, with new developments in imaging technologies enhancing resolution and scanning times. The market sees growth in oncology, cardiology, and neurology applications, driven by the need for non-invasive diagnostic tools for accurate treatment planning.

Stationary PET-CT scanners dominate the market, while portable/mobile scanners show rapid growth for on-site diagnostics in remote areas. Hospitals lead in service provider usage, with diagnostic centers growing rapidly due to advanced imaging technologies and cost-effective services.

Oncology is the leading application for PET-CT scanners, with neurology showing surging demand. North America, led by the United States, dominates the market with advanced medical infrastructure and high healthcare expenditure. The Asia-Pacific region is the fastest-growing market due to increasing healthcare investments and rising prevalence of diseases.

Recent innovations like Philips’ Spectral CT 7500 RT and the world’s first Total-Body PET/CT scanner are driving improvements in diagnostic imaging. PET-CT scanners are becoming more efficient and accessible to meet the growing demand for precise medical diagnoses across various applications.



Read more at GlobeNewswire: PET-CT Scanner Device Market to Reach USD 3.98 Billion by